![Mike Raab](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mike Raab
Chief Executive Officer at
ARDELYX, INC.
Net worth: 10 M $ as of 31/05/2026
Profile
Michael G.
Raab is President, Chief Executive Officer & Director at Ardelyx, Inc. since 2009.
He is Chairman at TempestTx, Inc. since 2018.
He serves as Director at California Biomedical Innovation Alliance and at Tempest Therapeutics, Inc. since 2021.
He is a Member of the Governors Board at Biotechnology Innovation Organization since 2006.
Formerly, Mr. Raab was Executive Chairman at Amicus Therapeutics, Inc. from 2024 to 2026.
He was Director at Novalar Pharmaceuticals, Inc., Liquidia Technologies, Inc., ZP Opco, Inc., Hyperion Therapeutics, Inc., Cellgate, Inc., Novacea, Inc. from 2002 to 2009, and Millendo Therapeutics, Inc. He held Principal roles at Bristol Myers Squibb Co. and Repligen Corp.
He was Partner at NEA Management Co. LLC and New Enterprise Associates LLC from 2002 to 2008.
He was Senior Vice President at Therapeutics, Inc. and Senior Vice President-Therapeutics at Genzyme Corp.
from 1999 to 2002.
Mr. Raab completed undergraduate education at DePauw University in 1987.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARDELYX, INC. 0.7% | 15/06/2026 | 1,724,564 ( 0.7% ) | 10 M $ | 31/05/2026 |
| 27/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Mike Raab active positions
| Companies | Position | Start |
|---|---|---|
| ARDELYX, INC. | Chief Executive Officer | 01/03/2009 |
| TEMPEST THERAPEUTICS, INC. | Director/Board Member | 27/01/2026 |
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Chairman | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | 01/01/2006 |
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Director/Board Member | - |
Former positions of Mike Raab
| Companies | Position | End |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Chairman | 27/04/2026 |
Cellgate, Inc.
 Cellgate, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals products | Director/Board Member | 22/06/2009 |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 03/02/2009 |
New Enterprise Associates LLC
 New Enterprise Associates LLC Investment ManagersFinance Operates as a venture capital firm | Corporate Officer/Principal | 01/12/2008 |
| ░░░ ░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Training of Mike Raab
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
20
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Repligen Corp.
 Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Novalar Pharmaceuticals, Inc.
 Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceuticals | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Health Technology |
Cellgate, Inc.
Cellgate, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals products | Health Technology |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Finance |
DePauw University
 DePauw University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Therapeutics, Inc.
 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies and biomarkers for bone diseases | Health Technology |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Health Technology |
New Enterprise Associates LLC
New Enterprise Associates LLC Investment ManagersFinance Operates as a venture capital firm | Finance |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Mike Raab
